MRI for the Early Evaluation of Acute Intracerebral Hemorrhage
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
What happens in the borderzone of a cerebral hemorrhage remains widely onknown and furhter the best timing for doing MR to look for vascular pathology in cerebral hemorrhage has not yet been determined. In this study we do acute MRS, a non-invasive imaging mathod to detemine the biochemsty in the border zone and structural MRI for vascular malformation. We repeat structural MRI after 8 weeks.
| Condition | Intervention |
|---|---|
|
Cerebral Hemorrhage Intracranial Arteriovenous Malformations Intracranial Hemorrhage, Hypertensive Brain Neoplasms |
Device: MRI Scan with the specified sequences below: |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | MRI for Early Identification of Underlying Pathology in Patients With Acute Intracerebral Hemorrhage |
| Estimated Enrollment: | 60 |
| Study Start Date: | April 2012 |
| Estimated Primary Completion Date: | April 2014 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
Intracerebral Hemorrhage Patients
Patients admitted with acute intracerebral hemorrhage within 72 hours after symptom onset.Patients are included in the study for MRI studies
|
Device: MRI Scan with the specified sequences below:
Standard sequences: Axial T2, axial DWI, Sagittal T1, T2 flair og axial GRE-sequence. Susceptibility weighted imaging (SWI) Chemical Shift Imaging (CSI) multivoxel spectroscopi Post contrast 3D box reconstruction |
Detailed Description:
In this study we want to investigate the ability of MRI to identify underlying pathology (tumor or vascular malformations) in acute patients admitted with intracerebral hemorrhage (ICH). Today MRI-scan is normally done 3-4 weeks after symptom onset but very little is known about the early use of MRI to detect underlying pathology. This would allow an early intervension and less uncertainty for the patients.
We further want to investigate the metabolic penumbra-zone surrounding the hematoma. It is the current perception in the litterature that this zone represent a metabolic zone marked by apoptosis and inflammation rather than ischemia.
We are planning to:
When patients arrive in our stroke department they will within 7 hours be subject to MRI scan with the protocoled sequences. Standard sequences: Axial T2, axial DWI, Sagittal T1, T2 flair og axial GRE-sequence.
Susceptibility weighted imaging (SWI)
Chemical Shift Imaging (CSI) multivoxel spectroscopi
Post contrast 3D box reconstruction
After 8 weeks the patients are subject to another MRI-Scan in accordance with the standard clinical guideline to rule out underlying pathology.
After 3 month the patients are seen in the outpatient-clinic to follow-up evaluation.
To sum up the purpose of this present study is to conduct a pilot investigation of MRI in the early evaluation of ICH-patients. Second it is our intension to use multivoxel magnetic resonance spectroscopy to study the metabolic penumbra-zone surrounding the ICH.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Patients admitted with CT-demonstrated Intracerebral Hemorrhage (ICH) within 72 hours after symptom onset.
Inclusion Criteria:
- CT demonstrated ICH
- Cardiopulmonary stable
- Informed consent from patient or proxy
- No General contraindication of MRI
- Age above 18
Exclusion Criteria:
- Lack of informed consent
- lack of cooperability
Contacts and Locations| Contact: Hanne Christensen, MD, DMSci | 004521729416 | hchr0039@bbh.regionh.dk |
| Contact: Anders Christensen, MD, Ph.d | achr0019@bbh.regionh.dk |
| Denmark | |
| Bispebjerg University Hospital | Recruiting |
| Copenhagen, Capital Region, Denmark, DK-2400 | |
| Contact: Hanne Christensen, MD, Ph.d, DMSci hchr0039@bbh.regionh.dk | |
| Principal Investigator: Hanne Christensen, MD, Ph.d, DMSci | |
| Sub-Investigator: Anders F Christensen, MD, Ph.d | |
More Information
Publications:
| Responsible Party: | Hanne Christensen, Associate Research Professor, Consultant Neurologist, Bispebjerg Hospital |
| ClinicalTrials.gov Identifier: | NCT01689402 History of Changes |
| Other Study ID Numbers: | H-2-2012-009 |
| Study First Received: | September 18, 2012 |
| Last Updated: | September 18, 2012 |
| Health Authority: | Denmark: National Board of Health |
Additional relevant MeSH terms:
|
Nervous System Malformations Congenital Abnormalities Arteriovenous Malformations Aneurysm Hemangioma Brain Neoplasms Neoplasms Intracranial Arteriovenous Malformations Hemorrhage Intracranial Hemorrhages Intracranial Hemorrhage, Hypertensive Cerebral Hemorrhage Vascular Malformations Cardiovascular Abnormalities |
Cardiovascular Diseases Vascular Diseases Neoplasms, Vascular Tissue Neoplasms by Histologic Type Central Nervous System Neoplasms Nervous System Neoplasms Neoplasms by Site Brain Diseases Central Nervous System Diseases Nervous System Diseases Cerebrovascular Disorders Central Nervous System Vascular Malformations Intracranial Arterial Diseases Pathologic Processes |
ClinicalTrials.gov processed this record on May 19, 2013